Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Coronary Stents Market Snapshot (2022 to 2032)

As per the latest Future Market Insights (FMI) analysis, demand for coronary stents and portable coronary stents will rise exponentially in the coming years. An aging population and a rising prevalence of risk factors such as cardiovascular diseases (CVDs), complex lesions, diabetes, obesity, and others are expected to drive demand for coronary stents over the forecast period.

Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. It also helps in improving the symptoms of heart disease, such as angina and shortness of breath thereby, reducing the need for coronary bypass surgery. Thus, surgeons prefer stenting, as it is a minimally invasive procedure and post-operative recovery is relatively fast.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Coronary Stents Demand Analysis (2016 to 2021) Vs Market Outlook (2022 to 2032)

According to the WHO, in 2019, CVDs were among the major causes of mortality worldwide. In 2019, an estimated 17.9 million people died from CVDs, responsible for 32% of all worldwide mortalities. The global Coronary Stents market is expected to grow at a significant CAGR between 2022 and 2032, in comparison to the 7% CAGR registered from 2016 to 2021.

Furthermore, according to research published in the National Library of Medicine in June 2021, one of the CVDs, coronary artery disease (CAD), causes roughly 610,000 fatalities yearly (an estimated 1 in 4 deaths) and is the major cause of mortality in the USA. As a result, the unprecedented rise in CAD incidence is predicted to boost demand for an effective coronary stent device for treatment. This factor is expected to bolster the demand throughout the forecast period.

Which Drivers Underpin Coronary Stents Industry Expansion?

Increasing Prevalence of Obesity Likely to Augment the Overall Demand

The increasing global aging population is resulting in an increasing patient pool with major cardiovascular diseases. Also, hypertension is emerging as a major public health concern. Aged individuals are more prone to various cardiovascular diseases due to high total serum cholesterol levels.

Also, obesity is one of the major risk factors responsible for various cardiovascular diseases worldwide. Excessive weight or obesity causes abnormal or excessive accumulation of fats inside the artery lumen that causes several health problems such as coronary heart diseases. Hence, weight loss and obesity management are integral parameters to avoid any kind of cardiovascular disease.

According to WHO estimates, each year, 2.8 million deaths across the globe are due to diseases caused by obesity. Thus, the increasing aging and obese population are major factors expected to fuel the growth of the global coronary stents market over the forecast period.

Increasing the Number of Stenting Procedures to Push the Sales

Added advantages of stenting procedures include substantial improvement of blood flow and prevention of further damage to the heart muscle. Patients suffering from coronary artery blockage are prescribed coronary stenting. Angioplasty is the first line of treatment for patients suffering from acute coronary artery blockages. The number of patients undergoing stenting has been increasing steadily over the last decade. This is due to the emergence of outpatient coronary stenting procedures, which reduces long hospital stays. Further, the usage of bioabsorbable coronary scaffolds in coronary blockage has proven more beneficial over drug-eluting stents.

Therefore, an increasing number of cardiologists referring to stenting procedures for patients suffering from CAD is a major factor expected to fuel revenue growth of the coronary stents market in the near future.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Factors are limiting the Growth of the Coronary Stents Market?

Some of the leading factors limiting the growth of the market include-

  • Availability of Alternative Treatment Methods for Coronary Artery Disease
  • Stringent Regulations for Product Approval
  • Product Failure and Product Recalls
  • Complications Associated With Implantation of Stents
  • Declining Costs of Stents

USA is Dominating the Coronary Stents Market by Growing Prevalence of Coronary Artery Diseases

The North American region dominates the coronary stents market share by securing the maximum share during the forecast period. The USA is leading the market size due to the growing number of heart diseases and the rising patient who has CAD during the forecast period. However, the rising adoption of angioplasty among patients is increasing the all-over production of coronary stents, which increases the USA coronary stents market share.

According to National Center for Health Statistics, every year, 1 in 4 deaths in the USA are caused due to coronary artery disease (CAD). Approximately 785,000 people in the USA suffer from their first heart attack, and 470,000 suffer from myocardial infarction. In addition, due to changing lifestyle habits, smoking and pollution are increasing the prevalence of coronary artery diseases in the USA in recent years.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

United Kingdom Market for Coronary Stents Drives by Growing Healthcare Sector

The Europe region is capturing a significant market share due to rising government initiatives during the forecast period. The United Kingdom
coronary stents market is a prominent leader that contributes a significant share in the region by conducting new initiatives and investing in the healthcare sector during the forecast period. The key manufacturers have increased the United Kingdom
coronary stents market size by innovating advanced technology tools to treat patients efficiently in recent years. Moreover, the innovation of the PCI procedure is advanced and most accepted by the healthcare sector in the USA during the forecast period. In addition, this procedure helps to improve survivability and lower chest pain.

Korea Coronary Stents Market Boost by Growing Medical Infrastructure

The Asia Pacific coronary stents market is one of the fastest-growing regions during the forecast period capturing a high CAGR. Korea is one of the leading countries that increase the coronary stents market growth by growing medical infrastructure during the foreseen time. The manufacturers in Korea have been developing expensive medical devices and innovating as per end-users' demands to acquire maximum output in recent years. Moreover, these players are launching high-value medical consumables devices for the effective treatment of coronary disease patients, which is likely to increase the Korean coronary stents market size.

Japan Market for Coronary Stents Drives by Rising Awareness Related Coronary Treatment

Japan is another country in the Asia Pacific region that also capture the maximum share in the region during the forecast period. Rising awareness related to coronary treatment and the dropping price of coronary stents increased the Japan coronary stents market growth during the forecast period. Moreover, the Growing sedentary lifestyle and growing management of the disease are surging the demand for coronary stents in Japan during the forecast period. In addition, the growing center for cardiac disease and rising coronary stent implantation are flourishing the Japanese coronary stents market growth in recent years.

Country-wise Insights

How big is the Opportunity in the USA?

The increasing prevalence of coronary artery diseases (CAD) is likely to augment the market growth

The increasing prevalence of coronary artery disease is fuelling the demand for interventional cardiology treatment in the USA. Patients suffering from long-term CAD are opting for angioplasty as the first line of treatment.

According to National Center for Health Statistics, every year 1 in 4 deaths in the USA are caused due to coronary artery diseases (CAD) and approximately 785,000 people in the USA suffer from their first heart attack and 470,000 suffer from myocardial infarction.

This is due to changing lifestyle habits, smoking, pollution, and other factors. This increasing prevalence of coronary artery diseases and higher healthcare expenditure in lower-middle-income countries is projected to boost the growth of the global coronary stents market over the forecast period.

How Lucrative Are Opportunities in China?

Favorable Government Support for Healthcare Development to Push the Market Positively

Increased government investment in healthcare and conducting new initiatives to bring in devices at affordable prices in cost constraint markets such as China are influencing this market as well.

For instance, in China, to address inflated pricing and other issues in the delivery of expensive medical supplies, the Chinese government launched a centralized procurement scheme for high-value medical consumables in January 2021.

The government aims to use this initiative to skip the associated suppliers and buy the items straight from the manufacturers, lowering the inflated pricing. As a result, the cost of coronary stents has dropped dramatically in China. The average price of coronary stents has been reduced by 93 % since 2019 to grab the national tender.

Start-ups for Coronary Stents Market

Some key startups in the Coronary Stents market include-

  • Silk Road Medical produces devices for Transcarotid artery revascularization (TAR) procedures for carotid artery disease. Their products include the EnRoute Transcarotid Neuroprotection and the EnRoute Stent system. The ENROUTE Transcarotid Stent is intended to be used in conjunction with the Transcarotid Neuroprotection System (NPS) during the TCAR procedure. A small incision is made just above the collar bone to expose the common carotid artery in which a flexible sheath is placed directly into the carotid artery and connected to a system that will reverse the flow of blood away from the brain to protect against fragments of plaque.
  • Echopoint Medical is a leading developer of smart devices for monitoring coronary artery disease and microvascular dysfunction. The company is involved in the development of optical-fiber-based sensors that integrate into medical devices for monitoring cardiac health. It has developed its microcatheter device that uses nanomaterials and sensors that can be positioned into cardiovascular devices for detecting heart conditions by using iKOR technology.

Who are the Leading Players in the Coronary Stents Market?

The top Coronary Stents market players are constantly upgrading their offerings to help end users. They are investing in partnerships, acquisitions, collaborations, and new product launches to gain a competitive edge in the market. For instance:

  • In April 2021, Abbott announced the launch of the coronary imaging platform Ultreon 1.0 Software powered by Al in Europe. The software has been launched with the aim to improve the detection of calcium-based blockages and measuring vessel diameter during coronary stenting procedures.
  • In February 2021, Cardiovascular Systems Inc announced a partnership agreement with Chansu Vascular Technologies, LLC with an aim to develop peripheral and coronary drug-coated balloons for applications in drug-eluting stents.

Report Scope

Report Attribute Details
Growth Rate CAGR of 5.1% from 2022 to 2032
Market Value in 2022 US$ 33.36 Million
Market Value in 2032 US$ 51.2 Million
Base Year for Estimation 2021
Historical Data 2016 to 2021
Forecast Period 2022 to 2032
Quantitative Units Revenue in US$ Million and CAGR from 2022 to 2032
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
  • Product Type
  • Raw Material
  • End User
  • Region
Regions Covered
  • North America
  • Latin America
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa (MEA)
Key Countries Profiled
  • USA
  • Canada
  • Brazil
  • Mexico
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • China
  • Japan
  • South Korea
  • Malaysia
  • Singapore
  • Australia
  • New Zealand
  • GCC Countries
  • South Africa
  • Israel
Key Companies Profiled
  • Abbott
  • Medtronic
  • Boston Scientific Corporation
  • Terumo Corporation
  • B Braun Melsungen AG
  • Biotronik
  • Stentys SA
  • MicroPort Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical

Key Segments Covered in the Coronary Stents Industry Analysis

By Product:

  • Drug Eluting Stent (DES)
  • Bare Metal Stent (BMS)
  • Bioresorbable Vascular Stent (BVS)

By Raw Material:

  • Cobalt-Chromium
  • Stainless Steel
  • Platinum – Chromium
  • Nickel – Titanium
  • Polymer

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Cardiac Catheterization Laboratories

By Region:

  • North America
  • Latin America
  • Brazil
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Frequently Asked Questions

What is the expected market value for Coronary Stents in 2022?

As of 2022, the Coronary Stents market is slated to reach a valuation of US$ 33.36 Million.

At what rate will the Coronary Stents market flourish from 2022 to 2032?

From 2022 to 2032, sales of Coronary Stents are expected to grow at a 5.1% CAGR.

What is the expected market value for Coronary Stents in 2032?

By 2032, Future Market Insights expects the Coronary Stents market to reach US$ 51.2 Million.

Table of Content

1. Executive Summary | Coronary Stents Market

2. Assumptions and Acronyms Used

3. Research Methodology

4. Market Introduction

    4.1. Market Definition

    4.2. Market Taxonomy

5. Market Analysis Scenario

    5.1. Market Size (US$ Million) and Forecast

        5.1.1. Market Size and Y-o-Y Growth

        5.1.2. Absolute $ Opportunity

    5.2. Market Overview

        5.2.1. Value Chain

        5.2.2. Epidemiology of Cardiovascular Diseases

        5.2.3. Key Regulations and Reimbursement Scenario

        5.2.4. PEST Analysis

6. Market Dynamics

    6.1. Macro-economic Factors

    6.2. Drivers

        6.2.1. Supply Side

        6.2.2. Demand Side

    6.3. Restraints

    6.4. Opportunity

    6.5. Trends

7. Global Market Analysis and Forecast, By Product

    7.1. Introduction

        7.1.1. Basis Point Share (BPS) Analysis By Product

        7.1.2. Y-o-Y Growth Projections By Product

    7.2. Market Size (US$ Million) and Volume (Units) Forecast By Product

        7.2.1. Drug Eluting Stent (DES)

        7.2.2. Bare Metal Stent (BMS)

        7.2.3. Bioresorbable Vascular Stent (BVS)

    7.3. Global Market Attractiveness Analysis, By Product Type

8. Global Market Analysis and Forecast, By Raw Material

    8.1. Introduction

        8.1.1. Basis Point Share (BPS) Analysis By Raw Material

        8.1.2. Y-o-Y Growth Projections By Raw Material

    8.2. Market Size (US$ Million) Forecast By Raw Material

        8.2.1. Cobalt Chromium

        8.2.2. Stainless Steel

        8.2.3. Platinum – Chromium

        8.2.4. Nickel-Titanium

        8.2.5. Polymer

    8.3. Global Market Attractiveness Analysis, By Raw Material

9. Global Market Analysis and Forecast, By End User

    9.1. Introduction

        9.1.1. Basis Point Share (BPS) Analysis By End User

        9.1.2. Y-o-Y Growth Projections By End User

    9.2. Market Size (US$ Million) Forecast By End User

        9.2.1. Hospitals

        9.2.2. Ambulatory Surgical Centers

        9.2.3. Cardiac Catheterization Laboratories

    9.3. Market Attractiveness Analysis By End User

10. Global Market Analysis and Forecast, By Region

    10.1. Introduction

        10.1.1. Basis Point Share (BPS) Analysis By Region

        10.1.2. Y-o-Y Growth Projections By Region

    10.2. Market Size (US$ Million) Forecast By Region

        10.2.1. North America

        10.2.2. Latin America

        10.2.3. Brazil

        10.2.4. Western Europe

        10.2.5. Eastern Europe

        10.2.6. Asia Pacific Excluding Japan

        10.2.7. Japan

        10.2.8. Middle East and Africa (MEA)

    10.3. Market Attractiveness Analysis By Region

11. North America Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Basis Point Share (BPS) Analysis By Country

        11.1.2. Y-o-Y Growth Projections By Country

    11.2. Market Size (US$ Million) Forecast By Country

        11.2.1. USA

        11.2.2. Canada

    11.3. Market Size (US$ Million) Forecast By Product

        11.3.1. Drug Eluting Stent (DES)

        11.3.2. Bare Metal Stent (BMS)

        11.3.3. Bioresorbable Vascular Stent (BVS)

    11.4. Market Size (US$ Million) Forecast By Raw Material

        11.4.1. Cobalt Chromium

        11.4.2. Stainless Steel

        11.4.3. Platinum – Chromium

        11.4.4. Nickel-Titanium

        11.4.5. Polymer

    11.5. Market Size (US$ Million) Forecast By End User

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgical Centers

        11.5.3. Cardiac Catheterization Laboratories

    11.6. Market Attractiveness Analysis

        11.6.1. By Country

        11.6.2. By Product

        11.6.3. By Raw Material

        11.6.4. By End User

    11.7. Prominent Trends

    11.8. Drivers and Restraints: Impact Analysis

12. Latin America Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Basis Point Share (BPS) Analysis By Country

        12.1.2. Y-o-Y Growth Projections By Country

    12.2. Market Size (US$ Million) and Volume (Units) Forecast By Country

        12.2.1. Mexico

        12.2.2. Argentina

        12.2.3. Rest of Latin America

    12.3. Market Size (US$ Million) Forecast By Product

        12.3.1. Drug Eluting Stent (DES)

        12.3.2. Bare Metal Stent (BMS)

        12.3.3. Bioresorbable Vascular Stent (BVS)

    12.4. Market Size (US$ Million) Forecast By Raw Material

        12.4.1. Cobalt Chromium

        12.4.2. Stainless Steel

        12.4.3. Platinum - Chromium

        12.4.4. Nickel-Titanium

        12.4.5. Polymer

    12.5. Market Size (US$ Million) Forecast By End User

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgical Centers

        12.5.3. Cardiac Catheterization Laboratories

    12.6. Market Attractiveness Analysis

        12.6.1. By Country

        12.6.2. By Product

        12.6.3. By Raw Material

        12.6.4. By End User

    12.7. Prominent Trends

    12.8. Drivers and Restraints: Impact Analysis

13. Brazil Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Basis Point Share (BPS) Analysis By Country

        13.1.2. Y-o-Y Growth Projections By Country

    13.2. Market Size (US$ Million) Forecast By Product

        13.2.1. Drug Eluting Stent (DES)

        13.2.2. Bare Metal Stent (BMS)

        13.2.3. Bioresorbable Vascular Stent (BVS)

    13.3. Market Size (US$ Million) Forecast By Raw Material

        13.3.1. Cobalt Chromium

        13.3.2. Stainless Steel

        13.3.3. Platinum – Chromium

        13.3.4. Nickel-Titanium

        13.3.5. Polymer

    13.4. Market Size (US$ Million) Forecast By End User

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Cardiac Catheterization Laboratories

    13.5. Market Attractiveness Analysis

        13.5.1. By Product

        13.5.2. By Raw Material

        13.5.3. By End User

14. Western Europe Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Basis Point Share (BPS) Analysis By Country / Region

        14.1.2. Y-o-Y Growth Projections By Country

    14.2. Market Size (US$ Million) and Volume (Units) Forecast By Country / Region

        14.2.1. Germany

        14.2.2. France

        14.2.3. Italy

        14.2.4. Spain

        14.2.5. United Kingdom

        14.2.6. BENELUX

        14.2.7. Rest of Western Europe

    14.3. Market Size (US$ Million) Forecast By Product

        14.3.1. Drug Eluting Stent (DES)

        14.3.2. Bare Metal Stent (BMS)

        14.3.3. Bioresorbable Vascular Stent (BVS)

    14.4. Market Size (US$ Million) Forecast By Raw Material

        14.4.1. Cobalt Chromium

        14.4.2. Stainless Steel

        14.4.3. Platinum – Chromium

        14.4.4. Nickel-Titanium

        14.4.5. Polymer

    14.5. Market Size (US$ Million) Forecast By End User

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgical Centers

        14.5.3. Cardiac Catheterization Laboratories

    14.6. Market Attractiveness Analysis

        14.6.1. By Country

        14.6.2. By Product

        14.6.3. By Raw Material

        14.6.4. By End User

    14.7. Prominent Trends

    14.8. Drivers and Restraints: Impact Analysis

15. Eastern Europe Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Basis Point Share (BPS) Analysis By Country

        15.1.2. Y-o-Y Growth Projections By Country

    15.2. Market Size (US$ Million) and Volume (Units) Forecast By Country

        15.2.1. Russia

        15.2.2. Poland

        15.2.3. Rest of Eastern Europe

    15.3. Market Size (US$ Million) Forecast By Product

        15.3.1. Drug Eluting Stent (DES)

        15.3.2. Bare Metal Stent (BMS)

        15.3.3. Bioresorbable Vascular Stent (BVS)

    15.4. Market Size (US$ Million) Forecast By Raw Material

        15.4.1. Cobalt Chromium

        15.4.2. Stainless Steel

        15.4.3. Platinum – Chromium

        15.4.4. Nickel-Titanium

        15.4.5. Polymer

    15.5. Market Size (US$ Million) Forecast By End User

        15.5.1. Hospitals

        15.5.2. Ambulatory Surgical Centers

        15.5.3. Cardiac Catheterization Laboratories

    15.6. Market Attractiveness Analysis

        15.6.1. By Country

        15.6.2. By Product

        15.6.3. By Raw Material

        15.6.4. By End User

    15.7. Prominent Trends

    15.8. Drivers and Restraints: Impact Analysis

16. Asia Pacific Excluding Japan (APEJ) Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Basis Point Share (BPS) Analysis By Country / Region

        16.1.2. Y-o-Y Growth Projections By Country / Region

    16.2. Market Size (US$ Million) and Volume (Units) Forecast By Country / Region

        16.2.1. China

        16.2.2. India

        16.2.3. ASEAN

        16.2.4. Australia and New Zealand

        16.2.5. Rest of Asia Pacific Excluding Japan

    16.3. Market Size (US$ Million) Forecast By Product

        16.3.1. Drug Eluting Stent (DES)

        16.3.2. Bare Metal Stent (BMS)

        16.3.3. Bioresorbable Vascular Stent (BVS)

    16.4. Market Size (US$ Million) Forecast By Raw Material

        16.4.1. Cobalt Chromium

        16.4.2. Stainless Steel

        16.4.3. Platinum – Chromium

        16.4.4. Nickel-Titanium

        16.4.5. Polymer

    16.5. Market Size (US$ Million) Forecast By End User

        16.5.1. Hospitals

        16.5.2. Ambulatory Surgical Centers

        16.5.3. Cardiac Catheterization Laboratories

    16.6. Market Attractiveness Analysis

        16.6.1. By Country

        16.6.2. By Product

        16.6.3. By Raw Material

        16.6.4. By End User

    16.7. Prominent Trends

    16.8. Drivers and Restraints: Impact Analysis

17. Japan Market Analysis and Forecast

    17.1. Introduction

    17.2. Market Size (US$ Million) and Volume (Units) Forecast By Product

    17.3. Market Size (US$ Million) Forecast By Product

        17.3.1. Drug Eluting Stent (DES)

        17.3.2. Bare Metal Stent (BMS)

        17.3.3. Bioresorbable Vascular Stent (BVS)

    17.4. Market Size (US$ Million) Forecast By Raw Material

        17.4.1. Cobalt Chromium

        17.4.2. Stainless Steel

        17.4.3. Platinum – Chromium

        17.4.4. Nickel-Titanium

        17.4.5. Polymer

    17.5. Market Size (US$ Million) Forecast By End User

        17.5.1. Hospitals

        17.5.2. Ambulatory Surgical Centers

        17.5.3. Cardiac Catheterization Laboratories

    17.6. Market Attractiveness Analysis

        17.6.1. By Country

        17.6.2. By Product

        17.6.3. By Raw Material

        17.6.4. By End User

    17.7. Prominent Trends

    17.8. Drivers and Restraints: Impact Analysis

18. MEA (Middle East & Africa) Market Analysis and Forecast

    18.1. Introduction

        18.1.1. Basis Point Share (BPS) Analysis By Country

        18.1.2. Y-o-Y Growth Projections By Country

    18.2. Market Size (US$ Million) and Volume (Units) Forecast By Country

        18.2.1. GCC Countries

        18.2.2. South Africa

        18.2.3. North Africa

        18.2.4. Rest of Middle East and Africa

    18.3. Market Size (US$ Million) Forecast By Product

        18.3.1. Drug Eluting Stent (DES)

        18.3.2. Bare Metal Stent (BMS)

        18.3.3. Bioresorbable Vascular Stent (BVS)

    18.4. Market Size (US$ Million) Forecast By Raw Material

        18.4.1. Cobalt Chromium

        18.4.2. Stainless Steel

        18.4.3. Platinum – Chromium

        18.4.4. Nickel-Titanium

        18.4.5. Polymer

    18.5. Market Size (US$ Million) Forecast By End User

        18.5.1. Hospitals

        18.5.2. Ambulatory Surgical Centers

        18.5.3. Cardiac Catheterization Laboratories

    18.6. Market Attractiveness Analysis

        18.6.1. By Country

        18.6.2. By Product

        18.6.3. By Raw Material

        18.6.4. By End User

    18.7. Prominent Trends

    18.8. Drivers and Restraints: Impact Analysis

19. Competition Landscape

    19.1. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments, Company Share Analysis)

    19.2. Global Players

        19.2.1. TERUMO CORPORATION

        19.2.2. Boston Scientific Corporation

        19.2.3. Medtronic

        19.2.4. Vascular Concepts

        19.2.5. B. Braun Melsungen AG

        19.2.6. BIOTRONIK SE & Co. KG

        19.2.7. Abbott Laboratories

        19.2.8. Biosensors International Group, Ltd.

        19.2.9. HEXACATH

        19.2.10. STENTYS SA

Recommendations

Healthcare

Gastrointestinal Stent Market

Published : February 2023

Healthcare

Neurovascular Stent Retrievers Market

Published : November 2022

Healthcare

Ureteral Stent Market

Published : July 2022

Explore Healthcare Insights

View Reports